Raised serum leptin levels and sFlt-1/PlGF ratios increase the risk of preeclampsia, suggesting disturbances in angiogenesis [36], as supported by findings of increased levels of anti-angiogenic factors, such as sFLT1, sEndoglin, and endothelin 1. The gene discussed is LEP; the disease is preeclampsia.